Abstract:OBJECTIVE:To investigate the function and mechanism of miR-610 in lung cancer cell proliferation and invasion.METHODS:The expression of miR-610 was detected by real-time PCR in lung cancer cell lines 95D and 95C with different metastatic ability. miR-610 mimics and inhibitor were transfected into 95D and 95C cells, respectively, and CCK-8 kit and BrdU incorporation assay were used to detect the effect of miR-610 on lung cancer cell proliferation. Cell scratch test and Transwell test were used to detect the effect of miR-610 on lung cancer cell invasion. Bioinformatics software was used to predict the potential target genes of miR-610. Dual-luciferase reporter gene system and Western blot were applied to test whether miR-610 regulates GJA3 expression directly.RESULTS:The expression of miR-610 in the weakly metastatic lung cancer 95C cells was (8.75 ± 0.21) times higher than that in the highly metastatic lung cancer 95D cells (P < 0.01). BrdU incorporation assay showed that the number of proliferating 95C cells was (37.41 ± 2.39)% in the control group and (59.63 ± 4.57)% in the miR-610 mimics transfection group (P < 0.01). The number of proliferating 95D cells was (68.75 ± 4.28)% in the control group and (46.13 ± 3.27)% in the miR-610 mimics transfection group (P < 0.01). Cell scratch test showed that at 24 and 48 hours after scratching, the scratch width of 95C cells in the miR-610 inhibitor group was reduced to (58.74 ± 4.62)% and (34.63 ± 2.73)%, respectively, of the initial scratch width, both were significantly lower than that of blank control group and miR-610 inhibitor control group (P < 0.01 for both). The scratch width of 95D cells in the miR-610 inhibitor group was (88.59 ± 6.92)% and (72.24 ± 5.46)%, respectively, of the initial scratch width, and both were significantly higher than that of the blank control group and miR-610 inhibitor control group (P < 0.01 for both). Transwell assay showed that the numbers of invading 95C cells after transfection with miR-610 inhibitor was (112.4 ± 10.6) cells/square in the miR-610 inhibitor control group and (161.8 ± 12.5) cells/square in the miR-610 inhibitor group, indicating a significantly increased invasion ability of 95C cells in the miR-610 inhibitor transfection group (P < 0.01). The numbers of invading 95D cells after transfection with miR-610 mimics was (178.4 ± 12.3) cells/square in the miR-610 mimics control group and (76.7 ± 5.8) cells/square in the miR-610 mimics group, indicating a significantly decreased invasion ability of 95D cells in the miR-610 mimics transfection group (P < 0.01). These data indicated that miR-610 can suppress the invasion of lung cancer cells.CONCLUSION:miR-610 suppresses lung cancer cell proliferation and invasion by targeting GJA3 expression.

Mir‑338‑3p Inhibits A549 Lung Cancer Cell Proliferation and Invasion by Targeting AKT and Β‑catenin Signaling Pathways.

MiR-337 Suppresses Pancreatic Cancer Development Via STAT3/Wnt/β-catenin Axis.

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

Mir-433 Inhibits Breast Cancer Cell Growth Via the MAPK Signaling Pathway by Targeting Rap1a

Microrna-187 Inhibits Pten Expression And Promotes Cell Proliferation In Non-Small-Cell Lung Cancer

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

[Mir-144-3p Inhibits the Invasion and Metastasis of Lung Adenocarcinoma Cells by Targeting IRS1].

Mir-21 Promotes Growth, Invasion and Migration of Lung Cancer Cells by AKT/P-AKT/cleaved-caspase 3/MMP-2/MMP-9 Signaling Pathway.

Overexpression of mir-489-3p inhibits proliferation and migration of non-small cell lung cancer cells by suppressing the HER2/PI3K/AKT/Snail signaling pathway

MiR-181a-5p Inhibits Cell Proliferation and Migration by Targeting Kras in Non-Small Cell Lung Cancer A549 Cells

Transforming Growth Factor-Beta-Induced Mir-143 Expression In Regulation Of Non-Small Cell Lung Cancer Cell Viability And Invasion Capacity In Vitro And In Vivo

Tumor Suppressor Mir-22 Suppresses Lung Cancer Cell Progression Through Post-Transcriptional Regulation of Erbb3

[Mir-610 Suppresses Lung Cancer Cell Proliferation and Invasion by Targeting GJA3].

Effect and Molecular Mechanism of Mir-146A on Proliferation of Lung Cancer Cells by Targeting and Regulating MIF Gene

[Mir-2110 Affects the Biological Behaviors of Lung Adenocarcinoma by Regulating CDT1].

The Mir-4732-5p/xpr1 Axis Suppresses the Invasion, Metastasis, and Epithelial–mesenchymal Transition of Lung Adenocarcinoma Via the PI3K/Akt/GSK3β/Snail Pathway

MicroRNA-122-3p Inhibits Tumor Cell Proliferation and Induces Apoptosis by Targeting Forkhead Box O in A549 Cells.

MicroRNA-33b Inhibits Lung Adenocarcinoma Cell Growth, Invasion, and Epithelial-Mesenchymal Transition by Suppressing Wnt/β-catenin/ZEB1 Signaling

[Mir-30B-3p Inhibits the Proliferation and Invasion of Lung Adenocarcinoma by Targeting COX6B1].

MicroRNA-145 Inhibits Lung Cancer Cell Metastasis.

Mir-143-3p Targeting LIM Domain Kinase 1 Suppresses the Progression of Triple-Negative Breast Cancer Cells.